返回 Agenda
Session Chair(s)
Representative Invited
WHO, India
Speaker(s)
Current Status of Implementing China 2010 GMP
Representative Invited
China
US FDA’s Experience from Inspection of API Establishments in China
Gang Wang, PHD
U.S.FDA China Office, China
Current Issues Relating to GMP from EU Perspective
David Cockburn
European Medicines Agency, Netherlands
Head of Manufacturing and Quality Compliance Service